ALK and non-small cell lung carcinoma: Recent comprehensive studies of cancer genomes have further identified various chromosomal rearrangements, which often generate functional gene fusions encoding oncogenic proteins that can be applied to therapeutic targets, as exemplified by the BCR-ABL and EML4-ALK fusion genes in chronic myeloid leukemia [9] and non-small-cell lung cancer, respectively [10].